Cargando…
Diagnostic Performance of Putaminal Hypointensity on Susceptibility MRI in Distinguishing Parkinson Disease from Progressive Supranuclear Palsy: A Meta‐Analysis
BACKGROUND: Idiopathic Parkinson's disease (IPD) and progressive supranuclear palsy (PSP) have similar clinical signs and symptoms, making accurate clinical diagnosis difficult. T2* gradient echo (T2* GRE), susceptibility‐weighted imaging (SWI), and quantitative susceptibility mapping (QSM) are...
Autores principales: | Mao, Zhijuan, Yu, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941919/ https://www.ncbi.nlm.nih.gov/pubmed/36825057 http://dx.doi.org/10.1002/mdc3.13573 |
Ejemplares similares
-
Putaminal Hypointensity in the Parkinsonian Variant of Multiple System Atrophy: Simple Visual Assessment Using Susceptibility-Weighted Imaging
por: Lee, Jae-Hyeok, et al.
Publicado: (2011) -
Gait analysis may distinguish progressive supranuclear palsy and Parkinson disease since the earliest stages
por: Amboni, Marianna, et al.
Publicado: (2021) -
Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance
por: Grimm, Max-Joseph, et al.
Publicado: (2020) -
Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism
por: Sjöström, Henrik, et al.
Publicado: (2019) -
Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy‐Parkinsonism From Parkinson's Disease
por: Quattrone, Andrea, et al.
Publicado: (2022)